Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility

被引:34
作者
Jia, Lanqi [1 ]
Simpson, Robert D. [1 ]
Yuan, Jing [1 ]
Xu, Zhenrong [1 ]
Zhao, Wei [1 ]
Cacatian, Salvacion [1 ]
Tice, Colin M. [1 ]
Guo, Joan [1 ]
Ishchenko, Alexey [1 ]
Singh, Suresh B. [1 ]
Wu, Zhongren [1 ]
McKeever, Brian M. [1 ]
Bukhtiyarov, Yuri [1 ]
Johnson, Judith A. [1 ]
Doe, Christopher P. [2 ]
Harrison, Richard K. [1 ]
McGeehan, Gerard M. [1 ]
Dillard, Lawrence W. [1 ]
Baldwin, John J. [1 ]
Claremon, David A. [1 ]
机构
[1] Vitae Pharmaceut, Ft Washington, PA 19034 USA
[2] GlaxoSmithKline, King Of Prussia, PA 19406 USA
关键词
Renin; aspartyl protease; hypertension; structure-based drug design; OPTIMIZATION; DESIGN;
D O I
10.1021/ml200137x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure guided optimization of a series of nonpeptidic alkyl amine renin inhibitors allowed the rational incorporation of additional polar functionality. Replacement of the c-yclohexylmethyl group occupying the SI pocket with a (R)-(tetrahydropyran-3-yl)methyl group and utilization of a different attachment point led to the identification of clinical candidate 9. This compound demonstrated excellent selectivity over related and unrelated off-targets, >15% oral bioavailability in three species, oral efficacy in a double transgenic rat model of hypertension, and good exposure in humans.
引用
收藏
页码:747 / 751
页数:5
相关论文
共 24 条
[1]   Update on tissue renin-angiotensin systems [J].
Bader, Michael ;
Ganten, Detlev .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (06) :615-621
[2]   Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors [J].
Bezencon, Olivier ;
Bur, Daniel ;
Weller, Thomas ;
Richard-Bildstein, Sylvia ;
Remen, Lubos ;
Sifferlen, Thierry ;
Corminboeuf, Olivier ;
Grisostomi, Corinna ;
Boss, Christoph ;
Prade, Lars ;
Delahaye, Stephane ;
Treiber, Alexander ;
Strickner, Panja ;
Binkert, Christoph ;
Hess, Patrick ;
Steiner, Beat ;
Fischli, Walter .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) :3689-3702
[3]   Addressing time-dependent CYP 3A4 inhibition observed in a novel series of substituted amino propanamide renin inhibitors, a case study [J].
Chen, Austin ;
Dube, Daniel ;
Dube, Laurence ;
Gagne, Sebastien ;
Gallant, Michel ;
Gaudreault, Mireille ;
Grimm, Erich ;
Houle, Robert ;
Lacombe, Patrick ;
Laliberte, Sebastien ;
Liu, Suzanna ;
MacDonald, Dwight ;
Mackay, Bruce ;
Martin, David ;
McKay, Dan ;
Powell, David ;
Levesque, Jean-Francois .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) :5074-5079
[4]   SPECIES SPECIFICITY OF RENIN KINETICS IN TRANSGENIC RATS HARBORING THE HUMAN RENIN AND ANGIOTENSINOGEN GENES [J].
GANTEN, D ;
WAGNER, J ;
ZEH, K ;
BADER, M ;
MICHEL, JB ;
PAUL, M ;
ZIMMERMANN, F ;
RUF, P ;
HILGENFELDT, U ;
GANTEN, U ;
KALING, M ;
BACHMANN, S ;
FUKAMIZU, A ;
MULLINS, JJ ;
MURAKAMI, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7806-7810
[5]   RENIN INHIBITORS [J].
GREENLEE, WJ .
MEDICINAL RESEARCH REVIEWS, 1990, 10 (02) :173-236
[6]  
GREGG RE, 2011, AM DIAB ASS 71 SCI S
[7]   Direct renin inhibition and the kidney [J].
Hollenberg, Norman K. .
NATURE REVIEWS NEPHROLOGY, 2010, 6 (01) :49-55
[8]   Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides:: The discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets [J].
Maibaum, Juergen ;
Stutz, Stefan ;
Goeschke, Richard ;
Rigollier, Pascal ;
Yamaguchi, Yasuchika ;
Cumin, Frederic ;
Rahuel, Joseph ;
Baum, Hans-Peter ;
Cohen, Nissim-Claude ;
Schnell, Christian R. ;
Fuhrer, Walter ;
Gruetter, Markus G. ;
Schilling, Walter ;
Wood, Jeanette M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (20) :4832-4844
[9]   Application of Direct Renin Inhibition to Chronic Kidney Disease [J].
Mende, Christian W. .
CARDIOVASCULAR DRUGS AND THERAPY, 2010, 24 (02) :139-149
[10]  
Remuzzi Giuseppe, 2005, Kidney Int Suppl, pS57